top of page



Impactful scientific discoveries through world-class research

Mick Lee's paper was accepted into Circulation! Link coming soon.

Mick has been using CRISPR screening to dissect mechanisms of cardiomyocyte differentiation and function. It turns out that NF2 is crucial to regulate Wnt signaling throughout this process which involves a stepwise clearance of cell fate - restricting regulators through the modulation of BMP/Wnt-signaling pathways.

NF2 and AMOT cooperatively bind to YAP preventing YAP activation. The AMOT-NF2-YAP scaffold complex at the adherens junction is required for mesodermal lineage specification. 


This work has helped us to establish CRISPR screening with Mick and others continuing to use this powerful tool to ask other questions. We were also awarded a grant to fund our exploration of avenues to exploit NF2 and related pathways to modulate heart muscle function. 

Screenshot 2024-04-17 180008_edited.png

Roger made a statement as newly appointed appointed Vice-Dean (Research) to kick off 2024.

Roger was asked to provide some inspiration for the new calendar year. Welcome colleagues and collaborators to 2024.

"A new year with new beginnings. I've been asked to reflect. It is a wonderful time to be called to serve in the ecosystem as Vice-Dean (Research) at NUS Yong Loo Lin School of Medicine...."


"I count myself very privileged indeed to be working very hard with everyone ... for the practice of better medicine tomorrow."

CVRI collage.jpg
  • LinkedIn
Screenshot 2024-01-02 184345_edited_edit

Launch of Project RESET

Project RESET has launched. We have the lofty aim to improve and promote heart health in Singapore. Heart failure as a disease represents the tip of the iceberg - we are scanning deeper.

July 2023

The lab was awarded a CS-IRG Grant! 

Based on PhD student-now-post-doc Dr Mick Lee's work the lab will investigate the role of NF-YAP complexes in cardiomyocyte biology

July 2023

Dr Matias Autio has a manuscript is accepted for publication in eLife. 

Stable and improved genomic safe-harbours have utility in a wide range of biomedical and life science applications.

December 2023

Recent highlights

Matias' Genomic Safe Harbour paper is published in eLife

January 2024

Dr Matias Autio has identifed new genomic safe harbours for transgene insertion in hESCs with stable and safe gene expression in hESCs and differentiated cell types. Experimentally validated, the GSH and cell lines generated have a wide utility in biomedical and molecular research applications. 

The team built landing pads to allow for consistent integration of useful payloads using recombinases. 

Foo-Lab has been awarded a CS-IRG grant

July 2023

The lab has received funding to further study the molecular biology of YAP-NF2 complexes in heart function and disease. PhD student, now post-doc Mick Lee found that this pathway plays an important role in cardiomyocyte differentiation and biology using a genome-wide pooled CRISPR screen.

Knowing Mick and Roger, the project is ambitious, deep molecular biology and hopes to identify novel candidate therapeutics.

Project RESET has been launched in style with a visit from the health minister.

July 2023

Project RESET is lead by Prof, Roger Foo and involves collaborators across Singapore. It aims to lead the way and transform Singapore's heart health amidst the looming S.E. Asia heart failure crisis. How ? By focusing on the earlier, hidden risk factors, public health outreach and education and collecting data for deep science combining public health, clinical and genomics data. 

Seethe link below for more information and some of the press releases.

Foo Lab was present at Epigenetic Regulation of Cardiovascular Disease,
Gordon Research Conference, June 18-23,2023

Rijan representing Foo Lab at Gordon, see his post here 

bottom of page